Neurocrine Biosciences Set to Announce Q3 Financial Results

Author: Olivia Taylor Updated: 10-07-2025 04:12 PM

Neurocrine Biosciences Schedules Q3 Financial Results Call

Upcoming Conference Call and Webcast Set for October 28

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is gearing up to share its financial performance for the third quarter. The eagerly anticipated conference call and accompanying webcast will take place at 1:30 p.m. Pacific Time, or 4:30 p.m. Eastern Time, on October 28.

The timeline for the event includes significant announcements as follows:

Q3 2025 Press Release: Scheduled for 1:00 p.m. PT / 4:00 p.m. ET on October 28
Q3 2025 Conference Call: Conducted at 1:30 p.m. PT / 4:30 p.m. ET on the same day
Domestic Dial-In Number: 800-274-8461
International Dial-In Number: 203-518-9814
Conference ID: NBIX

Participants can access the webcast through Neurocrine Biosciences' official website under the Investors section. Following the live event, a recorded broadcast will be available for one month, ensuring that those unable to attend can still engage with the insights shared.

About Neurocrine Biosciences

Neurocrine Biosciences is at the forefront of creating breakthrough treatments in the field of neuroscience. Their mission revolves around alleviating suffering for individuals with significant unmet medical needs. The company focuses on developing innovative therapies for a variety of challenging conditions including neurological, neuroendocrine, and neuropsychiatric disorders.

The portfolio showcases FDA-approved medications targeting conditions such as tardive dyskinesia and chorea linked to Huntington's disease, along with treatments for classic congenital adrenal hyperplasia and endometriosis. With a promising pipeline that includes several candidates in crucial clinical stages, Neurocrine's dedication to addressing complex diseases and disorders is evident.

For three decades, Neurocrine has leveraged deep insights into the intricate relationships between brain function and bodily systems, pursuing advanced medical solutions. They remain relentless in their quest to manage and mitigate the impact of debilitating health issues, embodying the principle that patients deserve courageous scientific innovation.

To learn more about their endeavors and progress, interested parties can visit their website or follow Neurocrine on various social media platforms including LinkedIn, X, and Facebook.

Trademark mentions such as NEUROCRINE and YOU DESERVE BRAVE SCIENCE reflect the company's commitment to its brand and mission to contribute meaningfully to healthcare.

Frequently Asked Questions

What is the purpose of Neurocrine's upcoming conference call?

The conference call is intended to announce and discuss the financial results for the third quarter of 2025.

When will the Q3 financial results be released?

The financial results will be released on October 28, 2025, at 1:00 p.m. PT.

How can I access the conference call?

Individuals can join the conference call by dialing the specified numbers provided by Neurocrine Biosciences.

Where can I find more information about Neurocrine Biosciences?

More details about the company and its initiatives can be found on their official website.

What therapeutic areas does Neurocrine focus on?

Neurocrine focuses primarily on treating neurological, neuroendocrine, and neuropsychiatric disorders.

About The Author

Olivia Taylor here, a 26-year-old writer and financial advisor. After earning a degree in finance, I worked in the sector for years. I've always loved numbers and had a talent for simplifying difficult financial ideas so that anyone could understand. I wrote my first book because of this passion; it helps readers take charge of their financial futures by fusing real-life stories with useful financial advice.

Whether they are just beginning their careers, preparing for significant life events, or seeking to invest wisely, my goal with my writing is to enable people to make educated financial decisions. The foundation of my work is the conviction that security and freedom of the individual are largely determined by financial literacy. To further financial education, I run workshops and frequently write for financial blogs in addition to my books.

I like to travel, experience other cultures, and find inspiration in daily life when I'm not writing or examining market trends. My passion is utilizing sound financial practices to help people reach their financial objectives and lead the best lives possible.

Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.